Nome Químico: (S)-2-(1-(2-(2,3-Dihydrobenzofuran-5-yl)-2-oxoethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide
Sorrisos: O=C(N)C(C1=CC=CC=C1)([C@H]2CN(CC(C3=CC=C(OCC4)C4=C3)=O)CC2)C5=CC=CC=C5
Inchi: InChI=1S/C20H22O6S2/c21-17-3-1-13(11-19(23)24)9-15(17)5-7-27-28-8-6-16-10-14(12-20(25)26)2-4-18(16)22/h1-4,9-10,21-22H,5-8,11-12H2,(H,23,24)(H,25,26)
Identification, isolation and characterization of dimer impurities in antimuscarinic agent darifenacin hydrobromide
By Gupta, P. Badarinadh; Rao, B. Venkateswara; Douglas, S. Paul; Sharma, Hemant Kumar; Bharathi, D. Vijaya
From World Journal of Pharmaceutical Research (2017), 6(6), 1041-1063
Development and validation of HPLC method for determination of potential genotoxic impurities in darifenacin hydrobromide drug substance
By Patcha, Vinay Kumar; Gajbhiye, Susheela Bhai; Vundavilli, Jagadeesh Kumar; Kothapalli, S. R. Pavan Kumar; Sreenivas, N.; Ray, U. K.
From International Journal of Pharmacy and Pharmaceutical Research (2017), 8(2), 198-208
Development and validation of a stability-indicating RP-HPLC method for determination of darifenacin hydrobromide in bulk drugs
By Nazeerunnisa, Mohammed; Garikapati, Lakshmi; Bethanabhatla, Syama Sundar
From American Journal of Analytical Chemistry (2014), 5(17), 1239-1248